Back to RL Rokos Capital Management LLP

TEVATEVA

Showing 2 of 5 quarters

Position history for RLRokos Capital Management LLP's holdings in Teva Pharmaceutical Industries Limited

No. Rokos Capital Management exited its TEVA (Teva Pharmaceutical Industries) position in Q4 2025. Its Q3 2025 13F listed 743,929 shares worth $15M. Rokos Capital Management first reported TEVA in Q2 2023 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$15M

Total Shares Change

-743,929

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$31.21
0
2025-Q3
New
743,929
—
$15M0.1%$20.20
39

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used